Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Broad Carrier Screen without X-linked Disorders Invitae United States | 195 | 98 |
|
Invitae United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia Myriad Genetics, Inc. United States | 2 | 1 |
|
Congenital Adrenal Hyperplasia (CAH) Panel PreventionGenetics United States | 8 | 7 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 328 | 300 |
|
Congenital Adrenal Hyperplasia (CAH) via the CYP21A2 Gene PreventionGenetics United States | 1 | 1 |
|
CAH (21-Hydroxylase Deficiency) Gene Sequencing Quest Diagnostics Nichols Institute San Juan Capistrano United States | 1 | 1 |
|
CAH (21-Hydroxylase Deficiency) Common Mutations Quest Diagnostics Nichols Institute San Juan Capistrano United States | 1 | 1 |
|
Fulgent Genetics United States | 17 | 14 |
|
Institute of Human Genetics Medical University Innsbruck Austria | 1 | 1 |
|
Inherited Metabolic Disorders Panel Dhiti Omics Technologies Private Ltd India | 376 | 317 |
|
Congenital adrenal hyperplasia panel. 9-gene NGS panel. Genologica Medica Spain | 14 | 9 |
|
Genital Abnormalities / Sex Development Disorders Panel Genologica Medica Spain | 95 | 49 |
|
Adrenal hyperplasia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 4 | 4 |
|
Congenital Adrenal Hyperplasia (CYP21A2 Gene) Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
CYP21A2 deletion/duplication analysis Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency Bioarray Spain | 1 | 1 |
|
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency Bioarray Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.